https://clinicaltrials.gov/ct2/show/NCT04384367?type=Intr&cond=Migraine&sfpd_d=14&sel_rss=new14
Condition : Migraine
Interventions : Drug: Rizatriptan 10 mg + Naproxen 550mg; Drug: Maxalt 10Mg Tablet; Drug: Flanax 550mg; Drug: Placebo oral tablet
Sponsor : Eurofarma Laboratorios S.A.
Not yet recruiting
Efficacy and Safety of Rizatriptan-Naproxen (10/550 mg) in the Acute Treatment of Migraine
NCT04384367
Tue, 12 May 2020 12:00:00 EDT
Last Update Posted: 05/12/20 06:48AM
